Search for: "C Lillie"
Results 341 - 360
of 444
Sort by Relevance
|
Sort by Date
19 Aug 2010, 8:36 am
Eli Lilly & Co., (1988) 44 Cal.3d 1103, 1112, 245 Cal.Rptr. 658, 751 P.2d 923. [read post]
12 Aug 2010, 11:56 am
Clippert, Charles Lillie, John Shands, Cean Cohen, Edward Loomis, Leah Sheridan, Jeffrey Cotter, Pat Loraas, James Shiah, Thomas H. … [read post]
12 Aug 2010, 11:28 am
Id. at 8-9 ("[c]ausing a subpoena to be served, with notice that compliance with it by the complicit recipient would violate a court’s lawful order, cannot be characterized as 'legitimate'”). [read post]
15 Jul 2010, 2:39 pm
Eli Lilly & Co., 192 Cal. [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
25 Jun 2010, 3:35 pm
Lilly Ledbetter, plaintiff, Ledbetter v. [read post]
3 Jun 2010, 1:37 pm
Eli Lilly & Co., 854 N.E.2d 372 (Ind. [read post]
3 Jun 2010, 11:25 am
In 2008, the company was sold to the pharmaceutical giant Eli Lilly for $6.5 billion. [read post]
21 May 2010, 8:58 am
Eli Lilly &Co. fell short of that requirement. [read post]
27 Apr 2010, 10:58 pm
(The SPC Blog) EU: Originator drug companies hit by European ruling: C-62/09 Association of the British Pharmaceutical Industry (Managing Intellectual Property) EU: EPO – Convention on Biological Diversity and the exception to patentability for inventions which are contrary to ‘ordre public’ or morality (EPLAW) India: Patent office releases details on pharmaceutical product patents granted in last 3 years (Generic Pharmaceuticals and IP) (Spicy IP) Kenya: High Court… [read post]
14 Apr 2010, 8:18 am
Eli Lilly and Company, 2008-1248 (Mar. 22, 2010). [read post]
13 Apr 2010, 10:26 am
Eli Lilly & Co., No. 2008-1248, 2010 WL 1007369 (Fed. [read post]
7 Apr 2010, 12:35 am
This weblog is a venture shared by the IPKat's friend David C. [read post]
2 Apr 2010, 7:00 am
Para conseguir acessar o e-mail, “Hacker Croll” pesquisou código postal e data de nascimento do usuário em redes sociais. [read post]
28 Mar 2010, 5:07 pm
Chantal writes to inform him as follows: "The almost endless series of olanzapine cases (inter alia Eli Lilly patent EP 0 454 436) has now produced an interesting sequel in the Netherlands. [read post]
4 Mar 2010, 7:05 am
Well, coming in at number six is Peter C. [read post]
17 Feb 2010, 4:54 am
- MDU Resources Group - Covidien Public Limited Company - Eli Lilly Thanks to Ken Wagner of Peabody Energy Corp. and Matt Tolland of Wilson Sonsini for pointing some of these new ones out! [read post]
14 Jan 2010, 11:09 am
Lilly argues that the commercialization of generic atomoxetine before the expiration of the ‘590 Patent would constitute further infringement of the ‘590 Patent under 35 U.S.C. 271(a), (b), and/or (c). [read post]
3 Dec 2009, 8:59 pm
For example, the Federal Circuit could-similar to DC Circuit Local Rule 28(a)(1)(C)-define a "related case" as including "any pending case involving at least one of the same parties and the same or similar issues. [read post]
